Studies on lysosomes. 13. Effects of stilbamidine and hydroxystilbamidine on in vitro and in vivo systems.
D000505:Alopecia / Q000139:chemically induced; D000818:Animals; D002247:Carbon Isotopes; D002357:Cartilage Diseases / Q000139:chemically induced; D002403:Cathepsins / Q000037:antagonists & inhibitors / Q000378:metabolism; D004054:Diethylstilbestrol / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004427:Ear Diseases / Q000139:chemically induced; D000431:Ethanol / Q000494:pharmacology; D005966:Glucuronidase / Q000037:antagonists & inhibitors; D005994:Glycerophosphates; D006801:Humans; D037102:Lectins / Q000494:pharmacology; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000378:metabolism; D008247:Lysosomes / Q000187:drug effects* / Q000201:enzymology* / Q000378:metabolism / Q000528:radiation effects; D008291:Malate Dehydrogenase / Q000378:metabolism; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors; D011817:Rabbits; D011830:Radiation Effects; D013266:Stilbamidines / Q000494:pharmacology*; D013429:Sulfatases / Q000037:antagonists & inhibitors / Q000378:metabolism; D013501:Surface-Active Agents / Q000494:pharmacology; D014466:Ultraviolet Rays; D014529:Uridine / Q000378:metabolism; D014801:Vitamin A / Q000494:pharmacology
D002247:Carbon Isotopes; D005994:Glycerophosphates; D037102:Lectins; D013266:Stilbamidines; D013501:Surface-Active Agents; D014801:Vitamin A; D000431:Ethanol; D004054:Diethylstilbestrol; D008291:Malate Dehydrogenase; D010744:Phosphoric Monoester Hydrolases; D013429:Sulfatases; D005966:Glucuronidase; D002403:Cathepsins; D014529:Uridine; D004121:Dimethyl Sulfoxide